Position
Squarepoint Ops LLC in Tvardi Therapeutics, Inc.
Back to the book · All holders of TVRD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$36.6K$4.30 → $3.18
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 51.8K | $222.7K | — | — | — | 0.0% |
| Q1 2026 | 32.7K | $103.9K | $3.18 | −$36.6K | −$82.2K | 0.0% |